+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

An early and specific indicator of aminoglycoside nephrotoxicity: isoenzyme B of urinary N-acetyl-beta-D-glucosaminidase (NAG)



An early and specific indicator of aminoglycoside nephrotoxicity: isoenzyme B of urinary N-acetyl-beta-D-glucosaminidase (NAG)



Pathologie-Biologie 34(5): 342-345



88 patients (aged 55-96 years) with severe infections were treated during ten days with one of four different aminoglycosides: gentamicin, dibekacin, netilmicin (3 mg/kg/day) or amikacin (15 mg/kg/day). Creatinine clearance and urinary N-acetyl-glucosaminidase (NAG) activity were measured daily. In addition, NAG isoenzyme patterns were determined on the day of maximal urinary NAG excretion. Aminoglycoside-induced acute renal failure was more prevalent in the gentamicin group (42.8%) than in the dibekacin, netilmicin or amikacin groups (42.8%, 5.5% and 0% respectively). No relationship was found between total urinary NAG activity and nephrotoxic risk. Conversely, significantly elevated levels (p less than 0.001) of B isoenzyme were detected in the gentamicin group, whereas the highest A and I isoenzyme levels were found in the dibekacin and netilmicin groups. These results suggest that functional enzymuria with preferential urinary excretion of A and I isoenzymes should be distinguished from lesional enzymuria with preferential urinary excretion of the B isoenzyme. According to our data, the NAG-B isoenzyme may possibly be a specific marker of aminoglycoside nephrotoxicity.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 039242731

Download citation: RISBibTeXText

PMID: 3534703


Related references

Excretion of urinary n acetyl beta d glucosaminidase nag and its b isoenzyme as an indicator of gentamicin nephrotoxicity revaluation with an animal model. Pathologie Biologie 36(3): 240-244, 1988

Urinary N-acetyl-beta-D-glucosaminidase (NAG) in aminoglycoside nephrotoxicity. Journal of the Medical Association of Thailand 72(Suppl. 1): 42-46, 1989

Aminoglycoside nephrotoxicity and urinary excretion of N-acetyl-beta-D-glucosaminidase. Biology of the Neonate 53(4): 253-259, 1988

The predictive value of urinary N-acetyl-beta-D-glucosaminidase in evaluating aminoglycoside nephrotoxicity. Taiwan Yi Xue Hui Za Zhi. Journal of the Formosan Medical Association 84(10): 1099-1107, 1985

Value of urinary n acetyl beta d glucosaminidase ec 3.2.1.30 isoenzyme profiles in evaluating nephrotoxicity of aminoglycosides and cephalosporins. Revue de Medecine Interne 5(4): 321-327, 1984

Urinary N-acetyl-beta-D-glucosaminidase (NAG) isoenzyme profiles: a tool for evaluating nephrotoxicity of aminoglycosides and cephalosporins. Clinica Chimica Acta; International Journal of Clinical Chemistry 137(1): 1-11, 1984

Urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzyme B as a marker of the nephrotoxicity of gentamicin: re-test from an animal model. Pathologie-Biologie 36(3): 240-244, 1988

Urinary n acetyl beta d glucosaminidase activity as the indicator of cisplatin renal toxicity factors affecting increase of urinary n acetyl beta d glucosaminidase activity. Nishinihon Journal of Urology 48(4): 1197-1203, 1986

Urinary excretion of N-acetyl-glucosaminidase and beta-2-microglobulin as early markers of gentamicin nephrotoxicity in neonates. Developmental Pharmacology and Therapeutics 10(2): 145-152, 1987

Variation in the isoenzymes of N-acetyl-beta-D-glucosaminidase and protein excretion in aminoglycoside nephrotoxicity in the rat. Cell Biochemistry and Function 9(3): 209-214, 1991

Nephrotoxicity of aminoglycosides and cephalosporins. Value of examining the isoenzyme profile of N-acetyl-beta-D-glucosaminidase. La Revue de Medecine Interne 5(4): 321-327, 1984

Determination of urinary n acetyl beta d glucosaminidase excretion as parameter of nephrotoxicity due to cisplatin and effect of fosfomycin on its nephrotoxicity. Acta Obstetrica et Gynaecologica Japonica (Japanese Edition) 38(11): 2037-2044, 1986

Determination of urinary N-acetyl-beta-D-glucosaminidase (NAG) excretion as a parameter of nephrotoxicity due to cis-platin and the effect of fosfomycin (FOM) on its nephrotoxicity. Nihon Sanka Fujinka Gakkai Zasshi 38(11): 2037-2044, 1986

Increased serum and urinary N-acetyl-beta-D-glucosaminidase activity in human hypertension: early indicator of renal dysfunction. Clinical and Experimental Hypertension. Part A Theory and Practice 6(4): 879-896, 1984

Urinary excretion of N-acetyl-beta-glucosaminidase and the isoenzyme B in children with urinary tract infection. Pediatric Nephrology 8(5): C62, 1994